Sawicki, K. T., Chang, H., Shapiro, J. S., Bayeva, M., De Jesus, A., Finck, B. N., . . . Ardehali, H. (2018). Hepatic tristetraprolin promotes insulin resistance through RNA destabilization of FGF21. JCI Insight.
Stile di citazione ChicagoSawicki, Konrad T., Hsiang-Chun Chang, Jason S. Shapiro, Marina Bayeva, Adam De Jesus, Brian N. Finck, Jason A. Wertheim, Perry J. Blackshear, e Hossein Ardehali. "Hepatic Tristetraprolin Promotes Insulin Resistance Through RNA Destabilization of FGF21." JCI Insight 2018.
Citazione MLASawicki, Konrad T., et al. "Hepatic Tristetraprolin Promotes Insulin Resistance Through RNA Destabilization of FGF21." JCI Insight 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.